What is Kyverna Therapeutics, Inc.'s net change in cash?

Kyverna Therapeutics, Inc. (KYTX) reported net change in cash of -$91.9M in Q1 2026.

How has Kyverna Therapeutics, Inc.'s net change in cash changed year-over-year?

Kyverna Therapeutics, Inc.'s net change in cash decreased by 131.2% year-over-year, from -$39.75M to -$91.9M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Kyverna Therapeutics, Inc. KYTX Net Change in Cash

Net Change in Cash at other companies

Bristol-Myers SquibbBMY

-$635M-220%

Gilead SciencesGILD

$65M+103%

Climb Bio, Inc.CLYM

-$27.33M+53.1%

Artiva Biotherapeutics, Inc.ARTV

-$5.75M+40.3%

Iovance Biotherapeutics, Inc.IOVA

$33.44M-40.3%

Viridian Therapeutics, Inc.VRDN

-$36.04M-317%

Other financials

Income statement

See full

Operating income-$41.4M+12.7%

Net income-$39.7M+11.0%

EPS (diluted)-$0.66+35.9%

Balance sheet

See full

Cash & equivalents$32.2M-43.4%

Total debt$9.2M+32.1%

Total equity$195.6M-12.7%

Total assets$257.0M-1.4%

Cash flow

See full

Operating cash flow-$41.6M+7.4%

CapEx$2.0K-98.0%

Free cash flow-$33.5M+10.8%

Valuation

See full

Market cap$498.52M+276%

Enterprise value$475.49M+475%

Returns & leverage

See full

Return on equity-74.5%+74.4pp

Debt / equity0×0.0×

Current ratio8.1×+0.7×

Where this comes from

Reported directly by Kyverna Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kyverna Therapeutics, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kyverna Therapeutics, Inc.'s net change in cash?: Kyverna Therapeutics, Inc. (KYTX) reported net change in cash of -$91.9M in Q1 2026.
How has Kyverna Therapeutics, Inc.'s net change in cash changed year-over-year?: Kyverna Therapeutics, Inc.'s net change in cash decreased by 131.2% year-over-year, from -$39.75M to -$91.9M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.